UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

[News]

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa clinical trial of a novel combination drug therapy for B-cell cancers.

More... (https://www.news-medical.net/news/20170826/UC-San-Diego-researchers-receive-24182-million-grant-for-B-cell-cancer-clinical-trial.aspx)